Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,665 | 727 | 96.6% |
| Education | $372.97 | 14 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,535 | 88 | $0 (2024) |
| GlaxoSmithKline, LLC. | $997.37 | 78 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $832.96 | 58 | $0 (2021) |
| Novo Nordisk Inc | $770.70 | 68 | $0 (2024) |
| Astellas Pharma US Inc | $671.79 | 30 | $0 (2021) |
| Merck Sharp & Dohme LLC | $670.73 | 48 | $0 (2024) |
| ABBVIE INC. | $549.45 | 39 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $538.88 | 32 | $0 (2024) |
| Amgen Inc. | $381.91 | 28 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $372.38 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,644 | 86 | AstraZeneca Pharmaceuticals LP ($291.82) |
| 2023 | $1,477 | 87 | AstraZeneca Pharmaceuticals LP ($191.59) |
| 2022 | $1,289 | 80 | AstraZeneca Pharmaceuticals LP ($195.01) |
| 2021 | $1,226 | 85 | AbbVie Inc. ($159.03) |
| 2020 | $703.05 | 43 | Astellas Pharma US Inc ($176.40) |
| 2019 | $1,638 | 106 | Janssen Pharmaceuticals, Inc ($373.09) |
| 2018 | $1,635 | 130 | AstraZeneca Pharmaceuticals LP ($285.89) |
| 2017 | $1,426 | 124 | AstraZeneca Pharmaceuticals LP ($260.92) |
All Payment Transactions
741 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: ADHD | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/04/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: ADHD | ||||||
| 10/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $34.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.56 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.00 | General |
| 09/06/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $23.66 | General |
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/27/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Obesity | ||||||
| 08/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Cardio-renal | ||||||
| 08/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), TRADJENTA, JARDIANCE | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 63 | 4,888 | 8,150 | $702,014 | $243,269 |
| 2022 | 67 | 5,065 | 8,070 | $715,476 | $255,500 |
| 2021 | 76 | 5,224 | 7,725 | $704,045 | $268,384 |
| 2020 | 74 | 5,127 | 7,891 | $738,368 | $256,952 |
All Medicare Procedures & Services
280 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 419 | 1,012 | $217,312 | $80,712 | 37.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 186 | 186 | $32,550 | $22,287 | 68.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 154 | 162 | $12,960 | $11,592 | 89.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 66 | 367 | $16,515 | $11,029 | 66.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 58 | $16,425 | $7,021 | 42.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 20 | 20 | $36,000 | $6,196 | 17.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 27 | 30 | $10,500 | $6,150 | 58.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 320 | 729 | $14,580 | $6,093 | 41.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 427 | 791 | $28,872 | $5,960 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 103 | $15,390 | $5,716 | 37.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 207 | 338 | $15,336 | $5,563 | 36.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 244 | 389 | $25,480 | $5,063 | 19.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 273 | 485 | $22,505 | $5,009 | 22.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 111 | 119 | $10,259 | $4,051 | 39.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 44 | 46 | $39,100 | $3,868 | 9.9% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 16 | 16 | $28,800 | $3,774 | 13.1% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 16 | 17 | $3,825 | $3,749 | 98.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 108 | 230 | $7,188 | $3,671 | 51.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 20 | 40 | $6,000 | $3,458 | 57.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 165 | 173 | $3,565 | $3,419 | 95.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 78 | 78 | $11,700 | $2,670 | 22.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 105 | 126 | $13,556 | $2,456 | 18.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 151 | 273 | $6,928 | $2,407 | 34.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,600 | $2,015 | 77.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 11 | 44 | $3,300 | $1,879 | 56.9% |
About Dr. Michelle Deeves, DO
Dr. Michelle Deeves, DO is a Family Medicine healthcare provider based in Dublin, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1164622924.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Deeves, DO has received a total of $11,038 in payments from pharmaceutical and medical device companies, with $1,644 received in 2024. These payments were reported across 741 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($10,665).
As a Medicare-enrolled provider, Deeves has provided services to 20,304 Medicare beneficiaries, totaling 31,836 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 280 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Dublin, GA
- Active Since 07/20/2007
- Last Updated 05/13/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1164622924
Products in Payments
- FARXIGA (Drug) $829.39
- XARELTO (Drug) $666.97
- XIFAXAN (Drug) $550.04
- TRELEGY ELLIPTA (Drug) $523.17
- VRAYLAR (Drug) $494.41
- MYRBETRIQ (Drug) $381.51
- Kerendia (Drug) $372.38
- BREZTRI (Drug) $304.02
- ENTRESTO (Drug) $282.58
- NURTEC ODT (Drug) $272.29
- AIRSUPRA (Drug) $245.11
- JANUVIA (Drug) $233.32
- BELSOMRA (Drug) $232.42
- Ozempic (Drug) $207.43
- Prolia (Biological) $179.99
- ANORO ELLIPTA (Drug) $172.99
- INVOKANA (Drug) $159.97
- Victoza (Drug) $136.56
- SOLIQUA (Drug) $127.28
- Wegovy (Drug) $122.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dublin
Dr. Marvin Im, D.o, D.O
Family Medicine — Payments: $22,532
Dr. Robinette Huston, Md, MD
Family Medicine — Payments: $13,536
David Tate, M.d, M.D
Family Medicine — Payments: $12,699
Dr. Andy Williamson, M.d, M.D
Family Medicine — Payments: $11,235
Mr. Berrien Waters, M.d, M.D
Family Medicine — Payments: $10,563
Kirkland Kolbie, M.d, M.D
Family Medicine — Payments: $10,551